Biocon Malaysia facility wins UK approval for Semglee fill-finish operations
- UK MHRA approval covers Biocon’s Malaysia-based insulin fill-finish line for Semglee
- The approval supports Biocon’s biosimilar manufacturing and international supply capabilities